BANGALORE, INDIA: IT major Infosys Technologies said on Monday that it would design and implement the Research Informatics System (RISe) at Elan Pharmaceuticals, Inc, a biotechnology company, to accelerate discovery research using a co-creation engagement model that leverages Infosys’ existing intellectual property in this field.
As Elan’s informatics system, RISe will leverage Infosys’ Scientific Innovation Solution for knowledge collaboration, Infosys said in a press release.
Novel ways to unlock disparate data spread across in-house research labs and other commercial or public sources will be presented to scientists in context of their research needs. This will result in, among other things, a customized registry, and inventory and a workflow management system for biological entities, said the release.
“We are confident that partnering and collaborating with Infosys will create a comprehensive informatics platform for our discovery research needs,” said Ajay Shah, Director – Research Informatics, Elan Pharmaceuticals.
“We selected Infosys after a competitive Proof-of-Concept phase during which they fully established their credentials and investments in this changing field of discovery research, and demonstrated flexibility and maturity in terms of rapid application development using Agile and Scrum methodologies,” he added.
With Infosys’ solution and engagement model, Elan expects that it would be able to lower costs for scientific operation and facilitate innovation.
The co-creation engagement model enables Infosys to retain ownership of co-developed IP as part of the implementation, the release added. Relevant components of this reference implementation can be reused or repurposed by Infosys to deliver faster business benefits at other Life Sciences organizations.
“Elan’s vision to create a scalable research informatics system for scientists to collaborate better, dovetails perfectly with our investments in solutions that improve scientific innovation and our efforts to streamline discovery research,” said R Arun Kumar, head of Infosys’ Global Life Sciences Practice, Infosys Technologies.
Future versions of the software may enable integration of RISe with electronic lab notebook and analytical dashboards which will enable more efficient research knowledge management, the release said.